MajesTEC-4

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation - MajesTEC-4

Arms / Cohorts

Experimental:Arm A: Teclistamab-Lenalidomide (Tec-Len)

Not currently accepting

Active Comparator:Arm B: Lenalidomide Alone (Len)

Not currently accepting

Experimental:Arm C: Teclistamab-Alone (Tec)

Not currently accepting

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.